SCOPUS 정보 검색 플랫폼

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

Model for End-Stage Liver Disease (MELD) exception for Budd-Chiari syndrome

(3) Washburn, W Kenneth a,b Gish, Robert G c Kamath, Patrick S d

a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c CALIFORNIA PACIFIC MEDICAL CENTER (United States)

d Mayo Clinic (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIURETIC AGENT;

ARTICLE; ASCITES; BRAIN DISEASE; BUDD CHIARI SYNDROME; HUMAN; HYPERBILIRUBINEMIA; LIVER DISEASE; LIVER TRANSPLANTATION; PATIENT IDENTIFICATION; PATIENT SELECTION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK BENEFIT ANALYSIS; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME;

BUDD-CHIARI SYNDROME; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845474983 PISSN: 15276465 EISSN: 15276473 Source Type: Journal
DOI: 10.1002/lt.20964 Document Type: Article

Times cited : (11)

References (7)

1
- 0742270394
- The Budd-Chiari syndrome
- Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;359:578-585.
- (2004) N Engl J Med , vol.359 , pp. 578-585
- Menon, K.V.¹ Shah, V.² Kamath, P.S.³

2
- 10744232260
- Determinants of survival and the effect of portosystemic shunt in patients with Budd-Chiari syndrome
- Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EG, et al. Determinants of survival and the effect of portosystemic shunt in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-508.
- (2004) Hepatology , vol.39 , pp. 500-508
- Murad, S.D.¹ Valla, D.C.² de Groen, P.C.³ Zeitoun, G.⁴ Hopmans, J.A.⁵ Haagsma, E.G.⁶

3
- 0030060301
- Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation
- Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996;171:176-180.
- (1996) Am J Surg , vol.171 , pp. 176-180
- Hemming, A.W.¹ Langer, B.² Greig, P.³ Taylor, B.R.⁴ Adams, R.⁵ Heathcote, E.J.⁶

4
- 0026638912
- Portosystemic shunt versus orthotopic liver transplantation for Budd-Chiari syndrome
- Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for Budd-Chiari syndrome. Surg Gynecol Obstet 1992;174:453-459.
- (1992) Surg Gynecol Obstet , vol.174 , pp. 453-459
- Shaked, A.¹ Goldstein, R.M.² Klintmalm, G.B.³ Drazan, K.⁴ Husberg, B.⁵ Busuttil, R.W.⁶

5
- 4444361687
- Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experience
- Xu PQ, Ma XX, Ye XX, Feng LS, Dang XW, Zhao YF, et al. Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experience. Hepatobiliary Pancreat Dis Int 2004;3:391-394.
- (2004) Hepatobiliary Pancreat Dis Int , vol.3 , pp. 391-394
- Xu, P.Q.¹ Ma, X.X.² Ye, X.X.³ Feng, L.S.⁴ Dang, X.W.⁵ Zhao, Y.F.⁶

6
- 0037357040
- Spectrum of hemostatic derangements in Budd-Chiari syndrome
- Patil HP, Dayal S, Srivastava A, Pande GK, Acharya SK. Spectrum of hemostatic derangements in Budd-Chiari syndrome. Indian J Gastroenterol 2003;22:59-60.
- (2003) Indian J Gastroenterol , vol.22 , pp. 59-60
- Patil, H.P.¹ Dayal, S.² Srivastava, A.³ Pande, G.K.⁴ Acharya, S.K.⁵

7
- 11144355839
- The Budd-Chiari syndrome: Outcome after treatment with the transjugular intrahepatic portosystemic shunt
- Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
- (2004) Surgery , vol.135 , pp. 394-403
- Rossle, M.¹ Olschewski, M.² Siegerstetter, V.³ Berger, E.⁴ Kurz, K.⁵ Grandt, D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.